Suppr超能文献

播散性快速生长分枝杆菌感染

Disseminated infection with rapidly growing mycobacteria.

作者信息

Ingram C W, Tanner D C, Durack D T, Kernodle G W, Corey G R

机构信息

Department of Medicine, Duke University Medical Center, Durham, North Carolina.

出版信息

Clin Infect Dis. 1993 Apr;16(4):463-71. doi: 10.1093/clind/16.4.463.

Abstract

Disseminated infection with the rapidly growing mycobacteria Mycobacterium chelonae and Mycobacterium fortuitum is uncommon. Only eight cases were diagnosed at Duke University Medical Center (Durham, NC) over the last 14 years. We identified 46 other cases by review of the medical literature since 1960. We categorized these 54 cases into three groups according to underlying disease and outcome. Group 1 comprised patients with no identified immune defect, a kidney transplant, collagen vascular disease, or chronic renal failure; these patients usually presented with skin involvement and responded well to antimicrobial therapy (survival rate, 90%). Group 2 comprised patients with cell-mediated immune deficiency, lymphoma, or leukemia; they presented with widespread, multiorgan involvement and severe illness. The survival rate in this group was only 10%. Patients in group 3 (who had other underlying diseases) had intermediately severe illnesses and intermediate responses to therapy. These groups provide the basis for an understanding of disseminated infection secondary to rapidly growing mycobacteria and of the profound effect that unresolved immunosuppression has on survival.

摘要

播散性快速生长分枝杆菌感染,如龟分枝杆菌和偶然分枝杆菌感染并不常见。在过去14年里,杜克大学医学中心(北卡罗来纳州达勒姆)仅诊断出8例此类病例。通过回顾1960年以来的医学文献,我们又识别出46例。我们根据基础疾病和预后将这54例病例分为三组。第1组包括未发现免疫缺陷、接受肾移植、患有胶原血管病或慢性肾衰竭的患者;这些患者通常表现为皮肤受累,对抗菌治疗反应良好(生存率为90%)。第2组包括细胞介导免疫缺陷、淋巴瘤或白血病患者;他们表现为广泛的多器官受累和重症疾病。该组的生存率仅为10%。第3组患者(患有其他基础疾病)病情严重程度中等,对治疗的反应也处于中等水平。这些分组为理解快速生长分枝杆菌继发的播散性感染以及未解决的免疫抑制对生存的深远影响提供了基础。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验